President Trump signs executive order boosting glyphosate production using Defense Production Act, defended by RFK Jr., as MAHA activists protest outside.
President Trump signs executive order boosting glyphosate production using Defense Production Act, defended by RFK Jr., as MAHA activists protest outside.
Image generated by AI

Trump executive order invoking Defense Production Act to boost glyphosate supply triggers backlash from MAHA activists

Image generated by AI
Fact checked

President Donald Trump has signed an executive order invoking the Defense Production Act to shore up U.S. supplies of glyphosate and its key input, elemental phosphorus—an action that has drawn sharp criticism from parts of the Make America Healthy Again (MAHA) movement even as Health Secretary Robert F. Kennedy Jr. defended the move as a national security measure.

On Wednesday, President Donald Trump signed an executive order that invokes the Defense Production Act to prioritize domestic supplies of glyphosate-based herbicides—chemicals commonly used in agriculture and found in Bayer’s Roundup products—along with elemental phosphorus, an input used to make glyphosate.

In the order, Trump argued that maintaining an adequate supply of these materials is “crucial to the national security and defense, including food-supply security.” The directive tells the secretaries of Agriculture and Defense to determine nationwide priorities under the Defense Production Act needed to ensure an “adequate supply” of both elemental phosphorus and glyphosate-based herbicides.

The move has angered some MAHA-aligned activists, who have made pesticide exposure—especially glyphosate—a top concern and who say the decision undercuts promises they believed the administration made to reduce potentially harmful chemicals in the food system.

Kennedy, a longtime critic of glyphosate, defended the order as a national security step. In a statement reported by Reuters, he said the administration needed to address vulnerabilities created when “hostile actors control critical inputs,” arguing that expanding domestic production would help protect American families.

The backlash comes amid heavy litigation over glyphosate. Plaintiffs have filed tens of thousands of lawsuits alleging exposure to Roundup caused cancer. Bayer—which acquired Monsanto in 2018 and has repeatedly disputed claims that glyphosate causes cancer—recently proposed a $7.25 billion settlement to address the ongoing litigation, according to Reuters.

Public debate over glyphosate’s health risks remains contested and has produced different conclusions across institutions. The World Health Organization’s International Agency for Research on Cancer classified glyphosate as “probably carcinogenic to humans” in 2015, while the U.S. Environmental Protection Agency has said glyphosate is not likely to be carcinogenic to humans when used as directed.

MAHA supporters, meanwhile, have aired their frustration online. Reuters quoted Kelly Ryerson, co-executive director of American Regeneration and a prominent critic of glyphosate, saying she saw little hope of “preserving the MAHA vote” after the executive order. Reuters also reported that the group Moms Across America circulated a petition urging Trump to rescind the order.

The dispute adds to broader strains between MAHA health priorities and other parts of the administration’s agenda. On Friday, the Environmental Protection Agency rolled back Biden-era updates to the Mercury and Air Toxics Standards for coal-fired power plants, a decision the agency said would preserve existing 2012 requirements while easing compliance costs; public health and environmental groups warned the change could increase exposure to mercury and other hazardous pollutants.

With all U.S. House seats and a third of U.S. Senate seats up for election in November 2026, some MAHA-aligned organizers and strategists have argued the glyphosate decision could become a political liability for Republicans if it depresses support among health-focused voters who were part of Trump’s 2024 coalition.

What people are saying

Reactions on X to Trump's executive order invoking the Defense Production Act for glyphosate production are sharply divided. MAHA activists and health advocates decry it as a betrayal of health reform promises, highlighting cancer links and liability shields, with Rep. Thomas Massie introducing a bill to undo it. Agriculture Republicans praise it for safeguarding food security, while some defend the move as essential national security amid foreign supply risks, advocating a phased transition to alternatives.

Related Articles

President Trump signs executive order banning Anthropic AI from federal agencies amid Pentagon dispute, illustrated with banned AI screens, Pentagon, and courthouse symbols.
Image generated by AI

Trump orders US agencies to halt use of Anthropic AI technology

Reported by AI Image generated by AI

US President Donald Trump has directed federal agencies to immediately cease using Anthropic's AI technology. The order follows a dispute with the Pentagon, where the company refused unconditional military use of its Claude models. Anthropic has vowed to challenge the Pentagon's ban in court.

President Donald Trump's $12 billion farm aid program, aimed at offsetting trade policy impacts, largely benefits major commodity operations, drawing criticism from the Make America Healthy Again movement. The initiative prioritizes big agriculture, which relies on pesticides the coalition seeks to curb. This has sparked internal tensions within conservative ranks over environmental and health priorities.

Reported by AI

The journal Regulatory Toxicology and Pharmacology has retracted a 2000 paper claiming glyphosate is safe for humans, citing undisclosed Monsanto involvement and reliance on unpublished studies. This development highlights ongoing concerns about the herbicide's regulation in the US. Meanwhile, stingless bees in Peru's Amazon have gained legal rights in two regions for the first time.

US President Donald Trump signed an executive order recommending the easing of federal marijuana regulations, a potentially significant shift in the country's drug policy. The measure directs the attorney general to advance reclassification of the drug, possibly moving it from Schedule I to Schedule III. The decision aims to boost medical research and could affect the cannabis industry, though marijuana would remain federally illegal.

Reported by AI

On February 12, 2026, the Trump administration repealed the Environmental Protection Agency's 2009 Endangerment Finding, which had established greenhouse gases as threats to public health and welfare. President Trump and EPA Administrator Lee Zeldin announced the move at the White House, describing it as the largest deregulatory action in U.S. history. The repeal undermines the legal foundation for numerous federal climate regulations.

US President Donald Trump has directed all federal agencies to immediately cease using Anthropic's AI tools amid a dispute over military applications. The move follows weeks of clashes between Anthropic and Pentagon officials regarding restrictions on AI for mass surveillance and autonomous weapons. A six-month phase-out period has been announced.

Reported by AI

The second Trump administration has initiated sweeping reductions in federal science funding, affecting public health, climate research, and space exploration. Elon Musk, serving as a special adviser, led efforts through the Department of Government Efficiency to slash government spending. These moves mark a significant departure from decades of US investment in scientific progress.

 

 

 

This website uses cookies

We use cookies for analytics to improve our site. Read our privacy policy for more information.
Decline